Corteria Pharmaceuticals

Corteria Pharmaceuticals is a biopharmaceutical company headquartered in Paris, France, specializing in developing treatments for underserved subpopulations of heart failure. The company develops drugs for indications with unmet medical needs such as heart failure, sarcopenia, and obesity, enabling healthcare professionals to easily understand the disease biology of patients.